Surgical outcomes of a new affordable non-valved glaucoma drainage device and Ahmed glaucoma valve: comparison in the first year
BackgroundA new low-cost, indigenously manufactured, non-valved glaucoma drainage device (GDD) has been introduced and its design is based on the Baerveldt Glaucoma Device. We aim to demonstrate the efficacy and safety of this GDD (Aurolab aqueous drainage implant, AADI) vis-à-vis the valved device,...
Gespeichert in:
| Veröffentlicht in: | British journal of ophthalmology 2019-05, Vol.103 (5), p.659-665 |
|---|---|
| Hauptverfasser: | , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 665 |
|---|---|
| container_issue | 5 |
| container_start_page | 659 |
| container_title | British journal of ophthalmology |
| container_volume | 103 |
| creator | Pathak Ray, Vanita Rao, Divya P |
| description | BackgroundA new low-cost, indigenously manufactured, non-valved glaucoma drainage device (GDD) has been introduced and its design is based on the Baerveldt Glaucoma Device. We aim to demonstrate the efficacy and safety of this GDD (Aurolab aqueous drainage implant, AADI) vis-à-vis the valved device, Ahmed glaucoma valve (AGV), in the management of refractory glaucomas.DesignRetrospective, comparative, interventional.Participants Case review of consecutive patients who underwent GDD surgery by a single fellowship-trained surgeon at a Tertiary Centre between January 2014 and November 2016.Primary outcome measure Intraocular pressure (IOP).SecondaryAntiglaucoma medication (AGM), LogMAR best-corrected visual acuity (BCVA), complications.ResultsA total of 88 eyes of 83 patients were included; 36 eyes received AGV and 52 AADI. Preoperative parameters were similar between groups. Median follow-up was 13 and 12 months for AADI and AGV, respectively. Overall success rate was higher in AADI (92.3%) vs AGV (80.5%) (p |
| doi_str_mv | 10.1136/bjophthalmol-2017-311716 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2060869465</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2060869465</sourcerecordid><originalsourceid>FETCH-LOGICAL-b387t-bb1292c46f14129717b582504be536ee23f5c78ba8ba9f53719420fa4fcfe8e3</originalsourceid><addsrcrecordid>eNqNkc9rHCEUx6W0NNu0_0IReullUp_OqNNbCOkPCPTQ3EVnnruzOLrVmS255U-v6aYl9FQQfMrn-574IYQCuwAQ8oPbp8Nu2dkwp9BwBqoRAArkM7KBVup6pfrnZMMYUw2AhDPyqpR9PXIJ6iU5433fdroXG3L_fc3babCBpnUZ0oyFJk8tjfiTWu9THq0LSGOKzdGGI450G-xaQUvHbKdot0hHPE4DUhtHermbnyK_Ix9prQ82TyVFOkW67JD6KZeF3qHNr8kLb0PBN4_7Obn9dH179aW5-fb569XlTeOEVkvjHPCeD6300NZKgXKd5h1rHXZCInLhu0FpZ-vqfScU9C1n3rZ-8KhRnJP3p7aHnH6sWBYzT2XAEGzEtBbDmWRa9q3sKvruH3Sf1hzr4wznwLQC0fFK6RM15FRKRm8OeZptvjPAzIMk81SSeZBkTpJq9O3jgNXV7_ob_GOlAuIEuHn__21_ATDeox4</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2210871352</pqid></control><display><type>article</type><title>Surgical outcomes of a new affordable non-valved glaucoma drainage device and Ahmed glaucoma valve: comparison in the first year</title><source>PubMed Central</source><creator>Pathak Ray, Vanita ; Rao, Divya P</creator><creatorcontrib>Pathak Ray, Vanita ; Rao, Divya P</creatorcontrib><description>BackgroundA new low-cost, indigenously manufactured, non-valved glaucoma drainage device (GDD) has been introduced and its design is based on the Baerveldt Glaucoma Device. We aim to demonstrate the efficacy and safety of this GDD (Aurolab aqueous drainage implant, AADI) vis-à-vis the valved device, Ahmed glaucoma valve (AGV), in the management of refractory glaucomas.DesignRetrospective, comparative, interventional.Participants Case review of consecutive patients who underwent GDD surgery by a single fellowship-trained surgeon at a Tertiary Centre between January 2014 and November 2016.Primary outcome measure Intraocular pressure (IOP).SecondaryAntiglaucoma medication (AGM), LogMAR best-corrected visual acuity (BCVA), complications.ResultsA total of 88 eyes of 83 patients were included; 36 eyes received AGV and 52 AADI. Preoperative parameters were similar between groups. Median follow-up was 13 and 12 months for AADI and AGV, respectively. Overall success rate was higher in AADI (92.3%) vs AGV (80.5%) (p<0.001). The median IOP in mm Hg (Quartiles; IQR) (AADI 14 (10,15;5) vs AGV 16 (14,20;6)) and AGM (AADI: 0 (0,1;1) vs AGV 2 (1,2.75;1.75)) was significantly lower in the AADI group at last follow-up (p<0.001). LogMAR BCVA improved in both groups; complication rates (AADI 44.2% vs AGV 52.7%) were comparable (p=0.59).ConclusionsBoth procedures were effective in reduction of IOP and need for AGM. Nevertheless, overall success rate was higher in the AADI group and IOP and number of AGM required was significantly lower in the AADI group; this affordable GDD could have a tremendous impact in the management of refractory glaucomas in low-income to middle-income countries.</description><identifier>ISSN: 0007-1161</identifier><identifier>EISSN: 1468-2079</identifier><identifier>DOI: 10.1136/bjophthalmol-2017-311716</identifier><identifier>PMID: 29945893</identifier><language>eng</language><publisher>England: BMJ Publishing Group LTD</publisher><subject>Clinical outcomes ; Ethics ; Glaucoma ; Ophthalmology ; Patients ; Success ; Surgeons ; Surgery ; Surgical outcomes ; Transplants & implants</subject><ispartof>British journal of ophthalmology, 2019-05, Vol.103 (5), p.659-665</ispartof><rights>Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2019. All rights reserved. No commercial use is permitted unless otherwise expressly granted.</rights><rights>Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.</rights><rights>2019 Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2019. All rights reserved. No commercial use is permitted unless otherwise expressly granted.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b387t-bb1292c46f14129717b582504be536ee23f5c78ba8ba9f53719420fa4fcfe8e3</citedby><cites>FETCH-LOGICAL-b387t-bb1292c46f14129717b582504be536ee23f5c78ba8ba9f53719420fa4fcfe8e3</cites><orcidid>0000-0002-7830-283X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29945893$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Pathak Ray, Vanita</creatorcontrib><creatorcontrib>Rao, Divya P</creatorcontrib><title>Surgical outcomes of a new affordable non-valved glaucoma drainage device and Ahmed glaucoma valve: comparison in the first year</title><title>British journal of ophthalmology</title><addtitle>Br J Ophthalmol</addtitle><description>BackgroundA new low-cost, indigenously manufactured, non-valved glaucoma drainage device (GDD) has been introduced and its design is based on the Baerveldt Glaucoma Device. We aim to demonstrate the efficacy and safety of this GDD (Aurolab aqueous drainage implant, AADI) vis-à-vis the valved device, Ahmed glaucoma valve (AGV), in the management of refractory glaucomas.DesignRetrospective, comparative, interventional.Participants Case review of consecutive patients who underwent GDD surgery by a single fellowship-trained surgeon at a Tertiary Centre between January 2014 and November 2016.Primary outcome measure Intraocular pressure (IOP).SecondaryAntiglaucoma medication (AGM), LogMAR best-corrected visual acuity (BCVA), complications.ResultsA total of 88 eyes of 83 patients were included; 36 eyes received AGV and 52 AADI. Preoperative parameters were similar between groups. Median follow-up was 13 and 12 months for AADI and AGV, respectively. Overall success rate was higher in AADI (92.3%) vs AGV (80.5%) (p<0.001). The median IOP in mm Hg (Quartiles; IQR) (AADI 14 (10,15;5) vs AGV 16 (14,20;6)) and AGM (AADI: 0 (0,1;1) vs AGV 2 (1,2.75;1.75)) was significantly lower in the AADI group at last follow-up (p<0.001). LogMAR BCVA improved in both groups; complication rates (AADI 44.2% vs AGV 52.7%) were comparable (p=0.59).ConclusionsBoth procedures were effective in reduction of IOP and need for AGM. Nevertheless, overall success rate was higher in the AADI group and IOP and number of AGM required was significantly lower in the AADI group; this affordable GDD could have a tremendous impact in the management of refractory glaucomas in low-income to middle-income countries.</description><subject>Clinical outcomes</subject><subject>Ethics</subject><subject>Glaucoma</subject><subject>Ophthalmology</subject><subject>Patients</subject><subject>Success</subject><subject>Surgeons</subject><subject>Surgery</subject><subject>Surgical outcomes</subject><subject>Transplants & implants</subject><issn>0007-1161</issn><issn>1468-2079</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNqNkc9rHCEUx6W0NNu0_0IReullUp_OqNNbCOkPCPTQ3EVnnruzOLrVmS255U-v6aYl9FQQfMrn-574IYQCuwAQ8oPbp8Nu2dkwp9BwBqoRAArkM7KBVup6pfrnZMMYUw2AhDPyqpR9PXIJ6iU5433fdroXG3L_fc3babCBpnUZ0oyFJk8tjfiTWu9THq0LSGOKzdGGI450G-xaQUvHbKdot0hHPE4DUhtHermbnyK_Ix9prQ82TyVFOkW67JD6KZeF3qHNr8kLb0PBN4_7Obn9dH179aW5-fb569XlTeOEVkvjHPCeD6300NZKgXKd5h1rHXZCInLhu0FpZ-vqfScU9C1n3rZ-8KhRnJP3p7aHnH6sWBYzT2XAEGzEtBbDmWRa9q3sKvruH3Sf1hzr4wznwLQC0fFK6RM15FRKRm8OeZptvjPAzIMk81SSeZBkTpJq9O3jgNXV7_ob_GOlAuIEuHn__21_ATDeox4</recordid><startdate>20190501</startdate><enddate>20190501</enddate><creator>Pathak Ray, Vanita</creator><creator>Rao, Divya P</creator><general>BMJ Publishing Group LTD</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-7830-283X</orcidid></search><sort><creationdate>20190501</creationdate><title>Surgical outcomes of a new affordable non-valved glaucoma drainage device and Ahmed glaucoma valve: comparison in the first year</title><author>Pathak Ray, Vanita ; Rao, Divya P</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b387t-bb1292c46f14129717b582504be536ee23f5c78ba8ba9f53719420fa4fcfe8e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Clinical outcomes</topic><topic>Ethics</topic><topic>Glaucoma</topic><topic>Ophthalmology</topic><topic>Patients</topic><topic>Success</topic><topic>Surgeons</topic><topic>Surgery</topic><topic>Surgical outcomes</topic><topic>Transplants & implants</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Pathak Ray, Vanita</creatorcontrib><creatorcontrib>Rao, Divya P</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>British journal of ophthalmology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Pathak Ray, Vanita</au><au>Rao, Divya P</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Surgical outcomes of a new affordable non-valved glaucoma drainage device and Ahmed glaucoma valve: comparison in the first year</atitle><jtitle>British journal of ophthalmology</jtitle><addtitle>Br J Ophthalmol</addtitle><date>2019-05-01</date><risdate>2019</risdate><volume>103</volume><issue>5</issue><spage>659</spage><epage>665</epage><pages>659-665</pages><issn>0007-1161</issn><eissn>1468-2079</eissn><abstract>BackgroundA new low-cost, indigenously manufactured, non-valved glaucoma drainage device (GDD) has been introduced and its design is based on the Baerveldt Glaucoma Device. We aim to demonstrate the efficacy and safety of this GDD (Aurolab aqueous drainage implant, AADI) vis-à-vis the valved device, Ahmed glaucoma valve (AGV), in the management of refractory glaucomas.DesignRetrospective, comparative, interventional.Participants Case review of consecutive patients who underwent GDD surgery by a single fellowship-trained surgeon at a Tertiary Centre between January 2014 and November 2016.Primary outcome measure Intraocular pressure (IOP).SecondaryAntiglaucoma medication (AGM), LogMAR best-corrected visual acuity (BCVA), complications.ResultsA total of 88 eyes of 83 patients were included; 36 eyes received AGV and 52 AADI. Preoperative parameters were similar between groups. Median follow-up was 13 and 12 months for AADI and AGV, respectively. Overall success rate was higher in AADI (92.3%) vs AGV (80.5%) (p<0.001). The median IOP in mm Hg (Quartiles; IQR) (AADI 14 (10,15;5) vs AGV 16 (14,20;6)) and AGM (AADI: 0 (0,1;1) vs AGV 2 (1,2.75;1.75)) was significantly lower in the AADI group at last follow-up (p<0.001). LogMAR BCVA improved in both groups; complication rates (AADI 44.2% vs AGV 52.7%) were comparable (p=0.59).ConclusionsBoth procedures were effective in reduction of IOP and need for AGM. Nevertheless, overall success rate was higher in the AADI group and IOP and number of AGM required was significantly lower in the AADI group; this affordable GDD could have a tremendous impact in the management of refractory glaucomas in low-income to middle-income countries.</abstract><cop>England</cop><pub>BMJ Publishing Group LTD</pub><pmid>29945893</pmid><doi>10.1136/bjophthalmol-2017-311716</doi><tpages>7</tpages><orcidid>https://orcid.org/0000-0002-7830-283X</orcidid></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0007-1161 |
| ispartof | British journal of ophthalmology, 2019-05, Vol.103 (5), p.659-665 |
| issn | 0007-1161 1468-2079 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2060869465 |
| source | PubMed Central |
| subjects | Clinical outcomes Ethics Glaucoma Ophthalmology Patients Success Surgeons Surgery Surgical outcomes Transplants & implants |
| title | Surgical outcomes of a new affordable non-valved glaucoma drainage device and Ahmed glaucoma valve: comparison in the first year |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-18T17%3A50%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Surgical%20outcomes%20of%20a%20new%20affordable%20non-valved%20glaucoma%20drainage%20device%20and%20Ahmed%20glaucoma%20valve:%20comparison%20in%20the%20first%20year&rft.jtitle=British%20journal%20of%20ophthalmology&rft.au=Pathak%20Ray,%20Vanita&rft.date=2019-05-01&rft.volume=103&rft.issue=5&rft.spage=659&rft.epage=665&rft.pages=659-665&rft.issn=0007-1161&rft.eissn=1468-2079&rft_id=info:doi/10.1136/bjophthalmol-2017-311716&rft_dat=%3Cproquest_cross%3E2060869465%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2210871352&rft_id=info:pmid/29945893&rfr_iscdi=true |